Cargando…
P557: LIFETIME CLINICAL OUTCOMES OF CPX-351 VERSUS 7 + 3 MODELED FROM THE 5-YEAR RESULTS OF A RANDOMIZED PHASE 3 TRIAL FOR OLDER ADULTS WITH NEWLY DIAGNOSED HIGH-RISK OR SECONDARY ACUTE MYELOID LEUKAEMIA
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429718/ http://dx.doi.org/10.1097/01.HS9.0000969136.52097.4e |
| _version_ | 1785090781875273728 |
|---|---|
| author | Reifsnider, Odette Yarnoff, Ben Shoval, Hila Fan, Lin |
| author_facet | Reifsnider, Odette Yarnoff, Ben Shoval, Hila Fan, Lin |
| author_sort | Reifsnider, Odette |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429718 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104297182023-08-17 P557: LIFETIME CLINICAL OUTCOMES OF CPX-351 VERSUS 7 + 3 MODELED FROM THE 5-YEAR RESULTS OF A RANDOMIZED PHASE 3 TRIAL FOR OLDER ADULTS WITH NEWLY DIAGNOSED HIGH-RISK OR SECONDARY ACUTE MYELOID LEUKAEMIA Reifsnider, Odette Yarnoff, Ben Shoval, Hila Fan, Lin Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429718/ http://dx.doi.org/10.1097/01.HS9.0000969136.52097.4e Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Reifsnider, Odette Yarnoff, Ben Shoval, Hila Fan, Lin P557: LIFETIME CLINICAL OUTCOMES OF CPX-351 VERSUS 7 + 3 MODELED FROM THE 5-YEAR RESULTS OF A RANDOMIZED PHASE 3 TRIAL FOR OLDER ADULTS WITH NEWLY DIAGNOSED HIGH-RISK OR SECONDARY ACUTE MYELOID LEUKAEMIA |
| title | P557: LIFETIME CLINICAL OUTCOMES OF CPX-351 VERSUS 7 + 3 MODELED FROM THE 5-YEAR RESULTS OF A RANDOMIZED PHASE 3 TRIAL FOR OLDER ADULTS WITH NEWLY DIAGNOSED HIGH-RISK OR SECONDARY ACUTE MYELOID LEUKAEMIA |
| title_full | P557: LIFETIME CLINICAL OUTCOMES OF CPX-351 VERSUS 7 + 3 MODELED FROM THE 5-YEAR RESULTS OF A RANDOMIZED PHASE 3 TRIAL FOR OLDER ADULTS WITH NEWLY DIAGNOSED HIGH-RISK OR SECONDARY ACUTE MYELOID LEUKAEMIA |
| title_fullStr | P557: LIFETIME CLINICAL OUTCOMES OF CPX-351 VERSUS 7 + 3 MODELED FROM THE 5-YEAR RESULTS OF A RANDOMIZED PHASE 3 TRIAL FOR OLDER ADULTS WITH NEWLY DIAGNOSED HIGH-RISK OR SECONDARY ACUTE MYELOID LEUKAEMIA |
| title_full_unstemmed | P557: LIFETIME CLINICAL OUTCOMES OF CPX-351 VERSUS 7 + 3 MODELED FROM THE 5-YEAR RESULTS OF A RANDOMIZED PHASE 3 TRIAL FOR OLDER ADULTS WITH NEWLY DIAGNOSED HIGH-RISK OR SECONDARY ACUTE MYELOID LEUKAEMIA |
| title_short | P557: LIFETIME CLINICAL OUTCOMES OF CPX-351 VERSUS 7 + 3 MODELED FROM THE 5-YEAR RESULTS OF A RANDOMIZED PHASE 3 TRIAL FOR OLDER ADULTS WITH NEWLY DIAGNOSED HIGH-RISK OR SECONDARY ACUTE MYELOID LEUKAEMIA |
| title_sort | p557: lifetime clinical outcomes of cpx-351 versus 7 + 3 modeled from the 5-year results of a randomized phase 3 trial for older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429718/ http://dx.doi.org/10.1097/01.HS9.0000969136.52097.4e |
| work_keys_str_mv | AT reifsniderodette p557lifetimeclinicaloutcomesofcpx351versus73modeledfromthe5yearresultsofarandomizedphase3trialforolderadultswithnewlydiagnosedhighriskorsecondaryacutemyeloidleukaemia AT yarnoffben p557lifetimeclinicaloutcomesofcpx351versus73modeledfromthe5yearresultsofarandomizedphase3trialforolderadultswithnewlydiagnosedhighriskorsecondaryacutemyeloidleukaemia AT shovalhila p557lifetimeclinicaloutcomesofcpx351versus73modeledfromthe5yearresultsofarandomizedphase3trialforolderadultswithnewlydiagnosedhighriskorsecondaryacutemyeloidleukaemia AT fanlin p557lifetimeclinicaloutcomesofcpx351versus73modeledfromthe5yearresultsofarandomizedphase3trialforolderadultswithnewlydiagnosedhighriskorsecondaryacutemyeloidleukaemia |